Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. CapStar Financial Holdings, Inc.

17% sales growth and 8.01% return on equity

CapStar Financial Holdings, Inc. operates as the bank holding company for CapStar Bank that provides banking services to consumer and corporate customers located primarily in Tennessee, the United States.

CapStar Financial Holdings, Inc.’s sales growth this year is expected to be 8.4% and a negative 1.5% for next year.

Year-on-year quarterly revenue growth grew by 52.4%, now sitting on 107.85M for the twelve trailing months.

CapStar Financial Holdings, Inc.’s sales growth for the next quarter is 17%. The company’s growth estimates for the present quarter and the next is 437.5% and 9.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.01%.

Volatility

CapStar Financial Holdings, Inc.’s last day, last week, and last month’s current volatility was 0.16%, 0.52%, and 1.87%, respectively.

CapStar Financial Holdings, Inc.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.17% (day), 2.90% (last week), and 4.00% (last month), respectively.

CapStar Financial Holdings, Inc.’s Stock Yearly Top and Bottom Value

CapStar Financial Holdings, Inc.’s stock is valued at $18.32 at 23:22 EST, below its 52-week high of $19.13 and way above its 52-week low of $8.94.

CapStar Financial Holdings, Inc.’s Moving Average

CapStar Financial Holdings, Inc.’s worth is higher than its 50-day moving average of $17.31 and way above its 200-day moving average of $14.17.

3. Novo Nordisk A/S

9.5% sales growth and 69.7% return on equity

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide.

Novo Nordisk A/S’s sales growth this year is anticipated to be 6.6% and 8.4% for next year.

Year-on-year quarterly revenue growth declined by 0.9%, now sitting on 126.95B for the twelve trailing months.

Novo Nordisk A/S’s sales growth for the next quarter is 9.5%. The company’s growth estimates for the current quarter and the next is a negative 0% and 8.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 69.7%.

Volatility

Novo Nordisk A/S’s last day, last week, and last month’s current volatility was 0.92%, 1.09%, and 1.10%, respectively.

Novo Nordisk A/S’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.70% (day), 0.93% (last week), and 1.27% (last month), respectively.

Novo Nordisk A/S’s Stock Yearly Top and Bottom Value

Novo Nordisk A/S’s stock is valued at $72.17 at 23:22 EST, under its 52-week high of $75.86 and way higher than its 52-week low of $61.53.

Novo Nordisk A/S’s Moving Average

Novo Nordisk A/S’s value is higher than its 50-day moving average of $69.96 and higher than its 200-day moving average of $70.10.

4. Interpublic Group of Companies, Inc.

8.4% sales growth and 11.75% return on equity

The Interpublic Group of Companies, Inc. provides advertising and marketing services worldwide.

Interpublic Group of Companies, Inc.’s sales growth this year is anticipated to be 6.6% and 3.4% for next year.

Year-on-year quarterly revenue growth declined by 6.1%, now sitting on 8.06B for the twelve trailing months.

Interpublic Group of Companies, Inc.’s sales growth for the next quarter is 8.4%. The company’s growth estimates for the current quarter and the next is 36.4% and 65.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.75%.

Volatility

Interpublic Group of Companies, Inc.’s last day, last week, and last month’s current volatility was 0.56%, 1.42%, and 1.11%, respectively.

Interpublic Group of Companies, Inc.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.52% (day), 2.38% (last week), and 2.54% (last month), respectively.

Interpublic Group of Companies, Inc.’s Stock Yearly Top and Bottom Value

Interpublic Group of Companies, Inc.’s stock is valued at $30.60 at 23:22 EST, under its 52-week high of $30.83 and way above its 52-week low of $13.91.

Interpublic Group of Companies, Inc.’s Moving Average

Interpublic Group of Companies, Inc.’s worth is above its 50-day moving average of $28.98 and way higher than its 200-day moving average of $24.06.

5. Globus Medical, Inc.

42.1% sales growth and 7.03% return on equity

Globus Medical, Inc., a medical device company, focuses on the development and commercialization of implants that heal patients with musculoskeletal disorders.

Globus Medical, Inc.’s sales growth this year is anticipated to be 11.7% and 10.8% for next year.

Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 789.04M for the twelve trailing months.

Globus Medical, Inc.’s sales growth for the next quarter is 42.1%. The company’s growth estimates for the present quarter and the next is 27.6% and 500%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.03%.

Volatility

Globus Medical, Inc.’s last day, last week, and last month’s current volatility was 0.14%, 0.81%, and 1.10%, respectively.

Globus Medical, Inc.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.19% (day), 1.79% (last week), and 2.12% (last month), respectively.

Globus Medical, Inc.’s Stock Yearly Top and Bottom Value

Globus Medical, Inc.’s stock is valued at $69.75 at 23:22 EST, below its 52-week high of $70.00 and way above its 52-week low of $42.85.

Globus Medical, Inc.’s Moving Average

Globus Medical, Inc.’s worth is way higher than its 50-day moving average of $63.01 and way above its 200-day moving average of $60.74.

6. Stag Industrial, Inc.

13.6% sales growth and 8.05% return on equity

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States.

Stag Industrial, Inc.’s sales growth this year is anticipated to be 12.4% and 10.9% for next year.

Year-on-year quarterly revenue growth grew by 16.9%, now sitting on 483.41M for the twelve trailing months.

Stag Industrial, Inc.’s sales growth for the next quarter is 13.6%. The company’s growth estimates for the present quarter and the next is a negative 73.8% and negative -8.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.05%.

Volatility

Stag Industrial, Inc.’s last day, last week, and last month’s current volatility was 0.34%, 0.94%, and 0.97%, respectively.

Stag Industrial, Inc.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.21% (day), 1.31% (last week), and 1.80% (last month), respectively.

Stag Industrial, Inc.’s Stock Yearly Top and Bottom Value

Stag Industrial, Inc.’s stock is valued at $35.56 at 23:22 EST, under its 52-week high of $35.88 and way higher than its 52-week low of $22.18.

Stag Industrial, Inc.’s Moving Average

Stag Industrial, Inc.’s value is above its 50-day moving average of $32.91 and way above its 200-day moving average of $31.53.

LEAVE A REPLY

Please enter your comment!
Please enter your name here